Literature DB >> 17131332

Elucidation of a protein signature discriminating six common types of adenocarcinoma.

Gregory C Bloom1, Steven Eschrich, Jeff X Zhou, Domenico Coppola, Timothy J Yeatman.   

Abstract

Pathologists are commonly facing the problem of attempting to identify the site of origin of a metastatic cancer when no primary tumor has been identified, yet few markers have been identified to date. Multitumor classifiers based on microarray based RNA expression have recently been described. Here we describe the first approximation of a tumor classifier based entirely on protein expression quantified by two-dimensional gel electrophoresis (2DE). The 2DE was used to analyze the proteomic expression pattern of 77 similarly appearing (using histomorphology) adenocarcinomas encompassing 6 types or sites of origin: ovary, colon, kidney, breast, lung and stomach. Discriminating sets of proteins were identified and used to train an artificial neural network (ANN). A leave-one-out cross validation (LOOCV) method was used to test the ability of the constructed network to predict the single held out sample from each iteration with a maximum predictive accuracy of 87% and an average predictive accuracy of 82% over the range of proteins chosen for its construction. These findings demonstrate the use of proteomics to construct a highly accurate ANN-based classifier for the detection of an individual tumor type, as well as distinguishing between 6 common tumor types in an unknown primary diagnosis setting.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17131332     DOI: 10.1002/ijc.22041

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  14 in total

1.  Comparative proteomic analysis of non-small-cell lung cancer and normal controls using serum label-free quantitative shotgun technology.

Authors:  Jun Pan; Hai-Quan Chen; Yi-Hua Sun; Jun-Hua Zhang; Xiao-Yang Luo
Journal:  Lung       Date:  2008-05-09       Impact factor: 2.584

2.  Protein signature for non-small cell lung cancer prognosis.

Authors:  Wei Liu; Yong Wu; Libo Wang; Ling Gao; Yingping Wang; Xiaoliang Liu; Kai Zhang; Jena Song; Hongxia Wang; Thomas A Bayer; Laurel Glaser; Yezhou Sun; Weijia Zhang; Michael Cutaia; David Y Zhang; Fei Ye
Journal:  Am J Cancer Res       Date:  2014-05-26       Impact factor: 6.166

3.  The effect of artificial neural network model combined with six tumor markers in auxiliary diagnosis of lung cancer.

Authors:  Feifei Feng; Yiming Wu; Yongjun Wu; Guangjin Nie; Ran Ni
Journal:  J Med Syst       Date:  2011-09-01       Impact factor: 4.460

Review 4.  Gene expression profiling in patients with carcinoma of unknown primary site: from translational research to standard of care.

Authors:  John D Hainsworth; F Anthony Greco
Journal:  Virchows Arch       Date:  2014-02-01       Impact factor: 4.064

5.  A novel method for sample preparation of fresh lung cancer tissue for proteomics analysis by tumor cell enrichment and removal of blood contaminants.

Authors:  Luigi De Petris; Maria Pernemalm; Göran Elmberger; Per Bergman; Lotta Orre; Rolf Lewensohn; Janne Lehtiö
Journal:  Proteome Sci       Date:  2010-02-26       Impact factor: 2.480

6.  Undifferentiated pelvic adenocarcinomas: diagnostic potential of protein profiling and multivariate analysis.

Authors:  U J Roblick; F G Bader; C Lenander; U Hellman; K Zimmermann; S Becker; A Ost; A Alaiya; H-P Bruch; R Keller; L Mirow; B Franzén; T Ried; G Auer; J K Habermann
Journal:  Int J Colorectal Dis       Date:  2008-02-22       Impact factor: 2.571

Review 7.  Key clinical issues in renal cancer: a challenge for proteomics.

Authors:  Rosamonde E Banks; Rachel A Craven; Patricia Harnden; Sanjeev Madaan; Adrian Joyce; Peter J Selby
Journal:  World J Urol       Date:  2007-08-25       Impact factor: 4.226

Review 8.  Progress in epigenetic histone modification analysis by mass spectrometry for clinical investigations.

Authors:  Özlem Önder; Simone Sidoli; Martin Carroll; Benjamin A Garcia
Journal:  Expert Rev Proteomics       Date:  2015       Impact factor: 3.940

9.  Interlaboratory performance of a microarray-based gene expression test to determine tissue of origin in poorly differentiated and undifferentiated cancers.

Authors:  Catherine I Dumur; Maureen Lyons-Weiler; Christin Sciulli; Carleton T Garrett; Iris Schrijver; Tara K Holley; Juan Rodriguez-Paris; Jonathan R Pollack; James L Zehnder; Melissa Price; Jill M Hagenkord; C Ted Rigl; Ljubomir J Buturovic; Glenda G Anderson; Federico A Monzon
Journal:  J Mol Diagn       Date:  2007-12-13       Impact factor: 5.568

Review 10.  The current state of proteomics in GI oncology.

Authors:  Ying Lin; William S Dynan; Jeffrey R Lee; Zhao-Hua Zhu; Robert R Schade
Journal:  Dig Dis Sci       Date:  2008-12-23       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.